Literature DB >> 3005518

Presidential address: the histopathology of meningiomas. A reflection of origins and expected behavior?

J J Kepes.   

Abstract

Meningiomas and their principal cells of origin, the arachnoidal "cap" cells are unique in their morphology with multiple and sometimes seemingly contradictory features related to their origins and basic character. Some meningiomas express mesenchymal features either in histologic pattern (fibroblastic, lipo-myxochondro-osteoblastic differentiation), participation in other disease processes, e.g. taking part in the formation of rheumatoid nodules, or in storage phenomena shared with other mesenchymal cells of the body. At the same time they may display epithelial features, such as well-formed desmosomes ultrastructurally, papillary formations and intracellular lumina in cells that stain positively for various cell markers usually considered to characterize epithelial cells. Histologic similarities of meningiomas to various gliomas, schwannomas, neuroblastomas, fibrous histiocytomas, myxomas, chordomas, metastatic carcinomas, and in the cases of meningiomas with marked inflammatory infiltrates, to benign or malignant lymphoproliferative disorders involving the meninges may pose serious diagnostic problems. The localization and resectability of meningiomas are important factors related to long-term prognosis. Of the histologic features hemangiopericytomatous pattern, papillary formations, high cellularity (focal or diffuse) and invasion of the brain appear to correlate with potentially aggressive behavior, whereas cytologically aneuploidia, large number of mitoses, prominent nucleoli and cell necrosis suggest a guarded prognosis. However, some meningiomas with no detectable histologic features of malignancy may nevertheless metastasize to distant sites.

Entities:  

Mesh:

Year:  1986        PMID: 3005518

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  24 in total

Review 1.  Tumors of the meninges: proposed modifications of the World Health Organization classification.

Authors:  B W Scheithauer
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Osteoblastic meningiomas: clinico-pathological and immunohistochemical features of an uncommon variant.

Authors:  V Barresi; M Caffo; A Ieni; C Alafaci; G Tuccari
Journal:  J Neurooncol       Date:  2011-04-22       Impact factor: 4.130

3.  Secretory meningioma associated with numerous meningothelial rosettes.

Authors:  T Tada; K Ishii; S Oshima; H Hara; S Kobayashi
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

4.  Histopathologic indicators of recurrence in meningiomas: correlation with clinical and genetic parameters.

Authors:  Yoo-Jin Kim; Ralf Ketter; Wolfram Henn; Klaus D Zang; Wolf-Ingo Steudel; Wolfgang Feiden
Journal:  Virchows Arch       Date:  2006-10-03       Impact factor: 4.064

5.  Value of AgNOR method in predicting recurrence of meningioma.

Authors:  A P Boon; H Sharif
Journal:  J Clin Pathol       Date:  1989-09       Impact factor: 3.411

6.  Do folliculo-stellate adenomas of the pituitary gland exist or are they intrasellar meningiomas?

Authors:  H Vogel; D S Horoupian; G Silverberg
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

7.  A comparison of clinicopathological features and surgical outcomes between pediatric skull base and non-skull base meningiomas.

Authors:  Zhicen Li; Hao Li; Yuming Jiao; Ji Ma; Shuo Wang; Jizong Zhao; Yong Cao
Journal:  Childs Nerv Syst       Date:  2016-10-29       Impact factor: 1.475

8.  Expression of the c-erbB-2-encoded oncoprotein and progesterone receptor in human meningiomas.

Authors:  J Schlegel; B Ullrich; G Stumm; P Gass; I M Harwerth; N E Hynes; M Kiessling
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

9.  The expression of CMP-NeuAc: Gal beta 1,4GlcNAc alpha 2,6 sialyltransferase [EC 2.4.99.1] and glycoproteins bearing alpha 2,6-linked sialic acids in human brain tumours.

Authors:  H Yamamoto; Y Kaneko; D Vandermulen; D Kersey; E Mkrdichian; L Cerullo; J Leestma; J R Moskal
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

10.  The expression of survivin and Ki-67 in meningiomas: correlation with grade and clinical outcome.

Authors:  Fazilet Kayaselçuk; Suzan Zorludemir; Nebil Bal; Bulent Erdogan; Seyda Erdogan; Tahsin Erman
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.